Back to News Page
Source: AP News
Boomerang Ventures, a digital-health studio and fund, led a $2 million oversubscribed seed investment in SiteLabs—a startup transforming independent pharmacies into community hubs for preventive screening, clinical trial access and diagnostics. The round includes strategic backing from Labcorp Venture Fund and SC Launch, positioning SiteLabs to scale rapidly in underserved regions.
Source: Tech Point
“Independent pharmacies are an untapped infrastructure for improving healthcare access in America,” said Darren Schaupp, CEO of SiteLabs. “They know their communities, see patients regularly, and can close critical gaps in preventive care and research recruitment — if we give them the right tools and partnerships.” With its pioneering point-of-care platform, SiteLabs is enabling pharmacies to deliver diagnostic screenings, connect patients to clinical trials, and create new revenue streams while improving health outcomes. Led by Boomerang Ventures, SiteLabs just closed a $2 million seed round to transform neighborhood pharmacies into frontline hubs for preventive care and research participation.
Source: Indianapolis Business Journal
Boomerang Ventures has led a $2 million seed investment in SiteLabs, an Anderson, South Carolina–based startup helping independent pharmacies offer onsite diagnostic testing. Founded in 2020, SiteLabs provides a digital platform that supports screenings for diabetes, cholesterol, strep throat and more. Boomerang contributed $1 million to the round, joined by Labcorp Venture Fund and SC Launch Inc., the investment arm of the South Carolina Research Authority.
Boomerang Ventures has led a $2 million Seed Round for SiteLabs, a health tech startup transforming independent pharmacies into neighborhood hubs for preventive care and clinical research. With $1 million invested by Boomerang and additional backing from Labcorp Venture Fund and SC Launch, the funding will accelerate SiteLabs’ platform expansion to empower pharmacies with diagnostic tools, trial recruitment capabilities, and integrations that improve access, equity, and outcomes in healthcare.
Source: Morningstar
Santa Barbara City College (SBCC) has partnered with Mentavi Health to provide rapid, clinically validated ADHD evaluations for students. Through Mentavi’s asynchronous online diagnostic process, SBCC can deliver professional assessments within days instead of weeks, helping students access federally mandated accommodations faster.
Source: Psychiatric Times
Quintessence Psychiatry enhances ADHD assessments through Mentavi Health’s Diagnostic Evaluation, providing clinicians with data-driven insights and patients with clarity and compassion. Dr. Nona Kocher discusses how structured tools and open dialogue improve diagnostic accuracy, reduce stigma, and foster better patient engagement in treatment.
Source: Psychiatric Times
Telepsychiatry is evolving with tools like the Mentavi Diagnostic Evaluation—an asynchronous, clinically validated ADHD assessment for adults. This innovative platform improves diagnostic accuracy, reduces wait times, and enhances patient engagement while helping clinicians make more informed treatment decisions.
Source: Tech Point
Indy-based Boomerang Ventures and fellow Indianapolis company Respiratory Health Technologies are making waves as RHT closed its seed round to scale its doctor-invented SinuSauna® device. This milestone underscores the strength of Indiana’s health tech ecosystem.
Boomerang Ventures today announced that portfolio company Respiratory Health Technologies has successfully closed its seed financing round, marking a major milestone for both the Boomerang Studio and Fund. RHT, creator of the doctor-invented SinuSauna®, is pioneering drug-free respiratory wellness solutions in the $11B market.
Source: Yahoo! Finance
Respiratory Health Technologies has officially closed its seed financing round to scale its signature device, SinuSauna®, and accelerate growth in the respiratory wellness sector.
Back to News Page
